# Codex Review: medical_monitoring_release_dossier_contract_audit_20260803

Date: 2026-08-03
Delegated-agent output: direct Codex work; no delegated report was used.

## Verdict

Pass with a bounded fail-closed repair. The current release state remains blocked; no authority
was inferred or granted. The review-gate check was run through the Hermes workflow guard.

## Boundary Check

- Work stayed inside the workbench. Only the task-scoped context/prompt/review/metrics records,
  P10 ledger/traceability entries, the release-evidence revalidation module and its focused test
  were changed. No release/B6/C14 JSON, product UI, medical-writing surface, runtime DB or real
  project was changed.
- Ports 8911, 5174, 8910 and 4173 remained stopped.

## Codex Verification

- Reopened current coverage: six source files match recorded bytes/SHA, 16 gate rows are bound,
  B6/C14 snapshot matches, decision is `blocked`, B6 is `pending_review`, and no release-ready
  flag is observed.
- Reopened dossier revalidation: no persisted commercial dossier JSON is declared; report is
  `blocked`, non-authoritative and not a substitute for dossier/UAT/signoff evidence.
- Focused regression after repair: **73 passed** across release gate, dossier, dossier
  revalidation, release evidence revalidation, nonfunctional evidence and AI release contracts.
- Negative probes block absolute/traversal/symlink source paths, unknown gate status and tampered
  derived decision/B6 fields. `py_compile` passed; local Ruff executable was unavailable.
- Final source hashes: `services/api/app/monitoring_release_evidence_revalidation.py`
  `3853c35c19968322928e2297f2eb143c9a654f149f24ceb284faccb672e07ede`;
  focused test `f02b4c2564616be353c135f2c34971899bccdbb3008ac06e8ff05d533e6b1703`.

## Delegated-Agent Output Review

- The audit stayed on the declared release aggregation boundary. The repair is surgical and
  aligns release evidence with the existing safe-path patterns used by source/CAS/dossier
  revalidation. No synthetic browser/scientific/UAT evidence was created.
- The current persisted coverage remains fresh only as an integrity observation; it does not
  prove B6, CAS/source-token, runtime, provider, browser/scientific, UAT or commercial readiness.

## Residual Risk

- Formal B6 reviewer outcomes and aggregate/CAS/source-token replay remain external blockers.
- The five-tester/two-role/two-clean-round Playwright/scientific loop has not run; no real project
  ingestion or provider route has been exercised. Commercial dossier and human signoffs remain
  undeclared. These are release gates, not reasons to fabricate a dossier in this slice.
